MGQLX
Price
$17.41
Change
+$0.08 (+0.46%)
Updated
Oct 8 closing price
Net Assets
48.36M
RWIBX
Price
$75.10
Change
+$0.48 (+0.64%)
Updated
Oct 8 closing price
Net Assets
141.87B
Interact to see
Advertisement

MGQLX vs RWIBX

Header iconMGQLX vs RWIBX Comparison
Open Charts MGQLX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Stars L
Price$17.41
Change+$0.08 (+0.46%)
VolumeN/A
Net Assets48.36M
American Funds Capital World Gr&Inc R2
Price$75.10
Change+$0.48 (+0.64%)
VolumeN/A
Net Assets141.87B
MGQLX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
MGQLX vs. RWIBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGQLX is a StrongBuy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 142B vs. MGQLX (48.4M). RWIBX pays higher dividends than MGQLX: RWIBX (0.76) vs MGQLX (0.00). MGQLX was incepted earlier than RWIBX: MGQLX (12 years) vs RWIBX (23 years). MGQLX (2.21) is less costly to investors than RWIBX (1.51). MGQLX is a more actively managed with annual turnover of: 73.00 vs. RWIBX (27.00). MGQLX has a lower initial minimum investment than RWIBX: MGQLX (0) vs RWIBX (250). RWIBX annual gain was more profitable for investors over the last year : 11.86 vs. MGQLX (-15.05). RWIBX return over 5 years is better than : 47.46 vs. MGQLX (8.04).
MGQLXRWIBXMGQLX / RWIBX
Total Expense Ratio1.651.51109%
Annual Report Gross Expense Ratio2.211.51146%
Fund Existence12 years23 years-
Gain YTD10.17220.70949%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets48.4M142B0%
Annual Yield % from dividends0.000.76-
Returns for 1 year-15.0511.86-127%
Returns for 3 years25.9466.6739%
Returns for 5 years8.0447.4617%
Returns for 10 years48.8874.2766%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN21.360.36
+1.71%
Viridian Therapeutics
NYT55.270.41
+0.75%
New York Times Co
CUBWU10.57N/A
N/A
Lionheart Holdings
AMBI1.16-0.03
-2.52%
Ambipar Emergency Response
MAGN11.00-0.69
-5.90%
Magnera Corporation